CNS Drugs Journal Issues Research Articles in June 2022 Edition
June 04, 2022
June 04, 2022
CHAM, Switzerland, June 4 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its June 2022 edition:
Review Articles:
* Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis
* CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Cu . . .
Review Articles:
* Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis
* CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Cu . . .